SIMCARD Film-coated tablet Ref.[50448] Active ingredients: Simvastatin

Source: Health Products Regulatory Authority (ZA)  Revision Year: 2021  Publisher: iPharma (Pty) Ltd., 124 Elevation Avenue, Randjesfontein, MIDRAND, 1683, SOUTH AFRICA

4.1. Therapeutic indications

Hypercholesterolaemia

SIMCARD is indicated, in combination with diet, to decrease elevated serum total cholesterol and LDL-cholesterol in patients with:

  • Primary hypercholesterolaemia
  • Heterozygous familial hypercholesterolaemia, or
  • Mixed hyperlipidaemia

When response to diet or other nonpharmacological measures alone is not adequate.

Coronary heart disease

SIMCARD is indicated in patient with coronary heart disease and hypercholesterolaemia unresponsive to diet, to:

  • Reduce the risk of total morality, by reducing coronary death.
  • Reduce the risk of non-fatal myocardial infarction,
  • Reduce the risk of undergoing myocardial revascularisation procedures (coronary artery bypass grafting and percutaneous transluminal coronary angioplasty), and
  • Slow the progression of coronary atherosclerosis.

4.2. Posology and method of administration

The patient must follow a cholesterol-lowering diet before initiation of, and while on SIMCARD therapy.

Hypercholesterolaemia

Adults

Initial dose: 10 mg daily as a single dose in the evening. The dose of SIMCARD should be reduced if LDL-cholesterol levels fall below 1,94 mmol/l, or total plasma cholesterol levels fall below 3,6 mmol/l.

Coronary heart disease

Adults

Initial dose: 20 mg daily as a single dose in the evening.

Dosage adjustments: If required, the dose should be adjusted at intervals of not less than 4 weeks, up to a maximum of 80 mg daily as a single dose in the evening. SIMCARD can be taken with meals or on an empty stomach.

Dosage in renal insufficiency

SIMCARD does not undergo significant renal excretion, therefore modification of dose should not be necessary in patient with mild to moderate renal insufficiency. In patients with severe renal insufficiency SIMCARD therapy should be closely monitored and doses above 10 mg daily should be implemented with caution.

Concomitant therapy

SIMCARD is effective alone or in combination with bile acid sequestrants. When both medicines are prescribed, SIMCARD should be given 1 hour before or 4 hours after cholestyramine administration (see section 4.5). A maximum daily dose of 10 mg SIMCARD is recommended in patients taking cyclosporin, fibrates or niacin or concomitantly (see section 4.5).

4.9. Overdose

(See section 4.4 and section 4.8).

General measures should be adopted and liver should be monitored.

Treatment is symptomatic and supportive.

6.3. Shelf life

3 years.

6.4. Special precautions for storage

Polyethylene (HDPE) containers and closures.

Keep container tightly closed. Store in a dry place, below 25˚C. Protect from light.

Do not remove the blisters from the outer carton until required for use.

6.5. Nature and contents of container

White opaque polyethylene (HPDE) containers and closures (tamper evident) containing 28/30 tablets or white opaque PVC/aluminium blister packs containing 28/30 tablets per carton.

6.6. Special precautions for disposal and other handling

None.

© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.